Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Next-generation therapies for adrenocortical carcinoma
Barbara Altieri, Cristina L. Ronchi, Matthias Kroiß, et al.
Best Practice & Research Clinical Endocrinology & Metabolism (2020) Vol. 34, Iss. 3, pp. 101434-101434
Closed Access | Times Cited: 82

Showing 1-25 of 82 citing articles:

CXCR4-targeted theranostics in oncology
Andreas K. Buck, Sebastian E. Serfling, Thomas Lindner, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2022) Vol. 49, Iss. 12, pp. 4133-4144
Open Access | Times Cited: 83
CDK1 serves as a therapeutic target of adrenocortical carcinoma via regulating epithelial–mesenchymal transition, G2/M phase transition, and PANoptosis
Liwen Ren, Yihui Yang, Wan Li, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 70
miRNAs orchestration of adrenocortical carcinoma - Particular emphasis on diagnosis, progression and drug resistance
Walaa A. El‐Dakroury, Heba M. Midan, Ahmed I. Abulsoud, et al.
Pathology - Research and Practice (2023) Vol. 248, pp. 154665-154665
Closed Access | Times Cited: 28
The potential role of miRNAs in the pathogenesis of adrenocortical carcinoma – A focus on signaling pathways interplay
Heba M. Midan, Gouda K. Helal, Ahmed I. Abulsoud, et al.
Pathology - Research and Practice (2023) Vol. 248, pp. 154690-154690
Closed Access | Times Cited: 25
Adrenocortical Carcinoma: Updates of Clinical and Pathological Features after Renewed World Health Organisation Classification and Pathology Staging
Alfred K. Lam
Biomedicines (2021) Vol. 9, Iss. 2, pp. 175-175
Open Access | Times Cited: 44
New Findings on Presentation and Outcome of Patients With Adrenocortical Cancer: Results From a National Cohort Study
Soraya Puglisi, Anna Calabrese, Francesco Ferraù, et al.
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 108, Iss. 10, pp. 2517-2525
Closed Access | Times Cited: 20
Current Evidence on Local Therapies in Advanced Adrenocortical Carcinoma
Otilia Kimpel, Ulrich Dischinger, Barbara Altieri, et al.
Hormone and Metabolic Research (2024) Vol. 56, Iss. 01, pp. 91-98
Open Access | Times Cited: 7
Expression and Prognostic Relevance of PD-1, PD-L1, and CTLA-4 Immune Checkpoints in Adrenocortical Carcinoma
Laura‐Sophie Landwehr, Barbara Altieri, Iuliu Sbiera, et al.
The Journal of Clinical Endocrinology & Metabolism (2024) Vol. 109, Iss. 9, pp. 2325-2334
Open Access | Times Cited: 6
A Review of Small-Molecule Inhibitors of One-Carbon Enzymes: SHMT2 and MTHFD2 in the Spotlight
Christine R. Cuthbertson, Zahra Arabzada, Armand Bankhead, et al.
ACS Pharmacology & Translational Science (2021) Vol. 4, Iss. 2, pp. 624-646
Open Access | Times Cited: 35
Adrenocortical tumours in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendations
Calogero Virgone, Jelena Roganović, Peter Vorwerk, et al.
Pediatric Blood & Cancer (2021) Vol. 68, Iss. S4
Open Access | Times Cited: 35
The Role of Biomarkers in Adrenocortical Carcinoma: A Review of Current Evidence and Future Perspectives
Maja Mizdrak, Tina Tičinović Kurir, Joško Božić
Biomedicines (2021) Vol. 9, Iss. 2, pp. 174-174
Open Access | Times Cited: 34
A Comprehensive Investigation of Steroidogenic Signaling in Classical and New Experimental Cell Models of Adrenocortical Carcinoma
Sandra Sigala, Christina Bothou, David Pentón, et al.
Cells (2022) Vol. 11, Iss. 9, pp. 1439-1439
Open Access | Times Cited: 27
Adrenocortical carcinoma: current state of the art, ongoing controversies, and future directions in diagnosis and treatment
Omair A. Shariq, Travis J. McKenzie
Therapeutic Advances in Chronic Disease (2021) Vol. 12
Open Access | Times Cited: 31
Adrenocortical Carcinoma in Childhood: A Systematic Review
Maria Riedmeier, Boris Decarolis, Imme Haubitz, et al.
Cancers (2021) Vol. 13, Iss. 21, pp. 5266-5266
Open Access | Times Cited: 31
A novel patient-derived cell line of adrenocortical carcinoma shows a pathogenic role of germline MUTYH mutation and high tumour mutational burden
Laura‐Sophie Landwehr, Jochen Schreiner, Silke Appenzeller, et al.
European Journal of Endocrinology (2021) Vol. 184, Iss. 6, pp. 823-835
Open Access | Times Cited: 28
Immunotherapy in Adrenocortical Carcinoma: Predictors of Response, Efficacy, Safety, and Mechanisms of Resistance
Marta Araujo‐Castro, Eider Pascual‐Corrales, Javier Molina‐Cerrillo, et al.
Biomedicines (2021) Vol. 9, Iss. 3, pp. 304-304
Open Access | Times Cited: 28
Cellular landscape of adrenocortical carcinoma at single-nuclei resolution
David S. Tourigny, Barbara Altieri, Kerim Secener, et al.
Molecular and Cellular Endocrinology (2024) Vol. 590, pp. 112272-112272
Open Access | Times Cited: 4
Combination immunotherapy with ipilimumab and nivolumab in patients with advanced adrenocortical carcinoma: a subgroup analysis of CA209-538
Oliver Klein, Clare Senko, Matteo S. Carlino, et al.
OncoImmunology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 27
Tumor Microenvironment in Adrenocortical Carcinoma: Barrier to Immunotherapy Success?
Natalia Georgantzoglou, Stefania Kokkali, Gerasimos Tsourouflis, et al.
Cancers (2021) Vol. 13, Iss. 8, pp. 1798-1798
Open Access | Times Cited: 24
Management of adrenocortical carcinoma in Slovenia: a real-life analysis of histopathologic markers, treatment patterns, prognostic factors, and survival
Urska Bokal, Jera Jeruc, Tomaž Kocjan, et al.
Radiology and Oncology (2025) Vol. 59, Iss. 1, pp. 121-131
Open Access
Emerging role of IGF1R and IR expression and localisation in adrenocortical carcinomas
Rosa Catalano, Emma Nozza, Barbara Altieri, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access
A multi-objective artificial bee colony approach for identifying cancer driver pathways
Fernando M. Rodríguez-Bejarano, Miguel A. Vega‐Rodríguez, Sergio Santander‐Jiménez
Expert Systems with Applications (2025) Vol. 275, pp. 127071-127071
Closed Access
Wnt/β-catenin pathway activation is associated with glucocorticoid secretion in adrenocortical carcinoma, but not directly with immune cell infiltration
Tanja Maier, Laura-Sophie Landwehr, Alexandra Triebig, et al.
Frontiers in Endocrinology (2025) Vol. 16
Open Access
Adrenocortical carcinoma: a practical guide for clinicians
Martin Faßnacht, Soraya Puglisi, Otilia Kimpel, et al.
The Lancet Diabetes & Endocrinology (2025)
Open Access
Cancer Stemness Associated With Prognosis and the Efficacy of Immunotherapy in Adrenocortical Carcinoma
Xiaoxi Shi, Yuanlin Liu, Shuai Cheng, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top